重新思考阿尔茨海默氏症:新的miRNAs揭示了一个超出大脑范围的疾病
J S Novotný1,2, M Čarná1, E B Dammer3
1Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
Molecular psychiatry
|February 13, 2026
概括
阿尔茨海默氏病 (AD) 涉及循环中的微RNA (miRNA) 的广泛变化,包括新的变化. 这些发现表明,阿尔茨海默病可能是一种全身性疾病,而不仅仅是特定于大脑的疾病,为生物标志物和疗法开辟了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 阿尔茨海默氏症 (AD) 带来了重大的全球挑战,但其病原性仍然不完全理解.
- 新出现的证据表明,阿尔茨海默病患者的循环微RNA (miRNA) 发生了复杂的变化.
研究的目的:
- 使用元分析,全面描述与阿尔茨海默病相关的miRNAs的变化.
- 为了确定新的miRNAs和生物途径,涉及到AD的病变发生.
主要方法:
- 对22项研究的数据进行了两种元分析方法,涉及4186名个人.
- 识别了2895个miRNA的综合集,并分析了那些AD显著变化的miRNA.
主要成果:
- 鉴定了194个具有AD广泛变化的miRNA,包括32个以前与该疾病无关的新型miRNA.
- 对miRNA点的分析揭示了人们对生物学途径的理解不足,包括白蛋白信号传递,Toll受体信号传递,p38 MAPK和胰岛素/IGF途径.
- 在大脑外发现了几种已识别的"AD miRNAs",这表明它们有系统性作用.
结论:
- 阿尔茨海默病可能是一种全身性疾病,而不是专门针对大脑的疾病.
- 这些发现扩大了对miRNA参与AD病变发生的理解,并突出了潜在的系统性途径.
- 结果为开发新的AD生物标志物和miRNA向治疗提供了基础.
更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
相关概念视频
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...